国际妇产科学杂志 ›› 2025, Vol. 52 ›› Issue (1): 32-36.doi: 10.12280/gjfckx.20240765

• 妇科肿瘤研究:病例报告 • 上一篇    下一篇

原发性卵巢腺鳞癌一例

贾炎峰, 吴珍珍(), 王维红, 王玥元, 李娟   

  1. 730050 兰州,甘肃省妇幼保健院(甘肃省中心医院)妇科(贾炎峰,吴珍珍,王维红,李娟),病理科(王玥元);甘肃中医药大学第一临床医学院(吴珍珍)
  • 收稿日期:2024-08-23 出版日期:2025-02-15 发布日期:2025-02-14
  • 通讯作者: 吴珍珍,E-mail:2396530559@qq.com

A Case of Primary Ovarian Adenosquamous Carcinoma

JIA Yan-feng, WU Zhen-zhen(), WANG Wei-hong, WANG Yue-yuan, LI Juan   

  1. Department of Gynecology (JIA Yan-feng, WU Zhen-zhen, WANG Wei-hong, LI Juan), Department of Pathology (WANG Yue -yuan), Provincial Maternity and Child-Care Hospital(Gansu Province Central Hospital), Lanzhou 730050, China; First School of Clinical Medical, Gansu University of Chinese Medicine, Lanzhou 730000, China (WU Zhen-zhen)
  • Received:2024-08-23 Published:2025-02-15 Online:2025-02-14
  • Contact: WU Zhen-zhen, E-mail: 2396530559@qq.com

摘要:

腺鳞癌是一种同时具有腺癌和鳞癌成分的恶性肿瘤。原发性卵巢腺鳞癌十分罕见,发病机制及临床病理特征不详,且预后差。报告1例原发性卵巢腺鳞癌ⅣB期患者。患者为53岁女性,表现为下腹坠胀,经检查发现右侧附件区非均质回声。经过满意的肿瘤细胞减灭术、6个疗程的静脉化疗后,出现铂耐药复发。随后进行了腹主动脉旁淋巴结复发区域放射治疗,但3个月后再次出现肠吻合口肿瘤复发和肠梗阻,再次手术。原发性卵巢腺鳞癌首选手术治疗,晚期患者应考虑淋巴结清扫或取样活检,术后化疗采用铂类为基础的方案,而基因检测和免疫治疗可能为未来的治疗提供新方向。复发后应根据转移瘤成分选择个体化治疗方案。

关键词: 腺鳞癌, 卵巢肿瘤, 复发, 发病机制, 治疗, 抗药性, 肿瘤

Abstract:

Adenosquamous carcinoma is a malignant neoplasm exhibiting both adenocarcinoma and squamous cell carcinoma components. Primary ovarian adenosquamous carcinoma is exceedingly rare, with poorly understood pathogenesis and clinicopathological features, and carries a poor prognosis. This report presents a case of stage ⅣB primary ovarian adenosquamous carcinoma. The 53-year-old female patient presented with lower abdominal distension and was found to have a heterogeneous echoic mass in the right adnexal. Following optimal cytoreduction surgery and six cycles of intravenous chemotherapy, platinum- resistant recurrence occurred. Subsequently, she underwent radiotherapy to the para-aortic lymph node recurrence site. However, three months later, tumor recurrence at the intestinal anastomosis site led to bowl obstruction, necessitating further surgery. While surgical resection is the primary treatment for primary ovarian adenosquamous carcinoma, lymphadenectomy or sampling is recommended in advanced stages. Platinum-based chemotherapy is the standard post-operative regimen. Future treatment directions may involve genomic profiling and immunotherapy. For recurrence disease,individualized treatment strategies should be tailored to the metastatic site and characteristics.

Key words: Adenosquamous carcinoma, Ovarian neoplasms, Recurrence, Pathogenesis, Therapy, Drug resistance, neoplasm